GIS
PFE icon

Graphene Investments SAS’s Pfizer PFE Stock Holding History

Graphene Investments SAS’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
138,200
+21,500
+18% +$562K 1.94% 30
2026
Q1 		$3.28M Sell
116,700
-13,000
-10% -$346K 2.2% 9
2025
Q4 		$3.23M Hold
129,700
– – 2.02% 27
2025
Q3 		$3.3M Sell
129,700
-13,500
-9% -$333K 2.09% 16
2025
Q2 		$3.47M Buy
143,200
+27,700
+24% +$646K 2.26% 7
2025
Q1 		$2.93M Hold
115,500
– – 2.14% 16
2024
Q4 		$3.06M Hold
115,500
– – 2.12% 13
2024
Q3 		$3.34M Buy
+115,500
New +$3.37M 2.14% 9

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Graphene Investments SAS's PFE Position: Q2 2026 in Review

Graphene Investments SAS increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $562K and bringing the position to 138,200 shares worth $3.33M. The position accounts for 1.94% of the portfolio, ranked #30.

Graphene Investments SAS first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.47M in Q2 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Graphene Investments SAS held 138,200 shares of Pfizer worth $3.33M as of Q2 2026.
  • Graphene Investments SAS bought 21,500 Pfizer shares in Q2 2026, an estimated $562K.
  • Pfizer made up 1.94% of Graphene Investments SAS's portfolio in Q2 2026, its #30 holding.
  • Graphene Investments SAS first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • Graphene Investments SAS's Pfizer position peaked at $3.47M in Q2 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Graphene Investments SAS's 13F filing for Q2 2026, filed 20 Jul 2026.